ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Altered pre-lamin A processing is a common mechanism leading to lipodystrophy
Author(s): Capanni C, Mattioli E, Columbaro M, Lucarelli E, Parnaik VK, Novelli G, Wehnert M, Cenni V, Maraldi NM, Squarzoni S, Lattanzi G
Source: HUMAN MOLECULAR GENETICS    Volume: 14    Issue: 11    Pages: 1489-1502    Published: JUN 1 2005  
Times Cited: 64     References: 59     
Abstract: Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPAR gamma) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein 1 (SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPAR gamma and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPAR gamma ligand activating the adipogenic program.
Document Type: Article
Language: English
Reprint Address: Lattanzi, G (reprint author), IOR, CNR, ITOI, Unit Bologna, Via Barbiano 1-10, I-40136 Bologna, Italy
Addresses:
1. IOR, CNR, ITOI, Unit Bologna, I-40136 Bologna, Italy
2. Ist Ortopedici Rizzoli, Cell Biol Lab, Bologna, Italy
3. IOR, Musculoskeletal Tissue Bank, Regenerat & Tissue Engn Lab, Bologna, Italy
4. Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh India
5. Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Rome, Italy
6. Univ Greifswald, Inst Human Genet, D-17487 Greifswald, Germany
Publisher: OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
Subject Category: Biochemistry & Molecular Biology; Genetics & Heredity
IDS Number: 928QF
ISSN: 0964-6906
DOI: 10.1093/hmg/ddi158
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo